Pharma & Biotech – Patent Litigation
C5 Conference, Amsterdam, February 27–28, 2018
On February 27 and 28, 2018, a Conference on patent litigation in the pharmaceutical and biotech sectors was organized by C5 Group companies in Amsterdam.
The Conference covered a range of current topics presented by in-house and external counsel as well as the author. Selected issues are described below.
In a first presentation Rob Aerts, IP Director, TiGenix, discussed the relationship of EU law applicable…
[…]
